Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what discussions his Department has had with the Therapeutic Taskforce on investigations into the use of Ivermaticin for the purposes of treating covid-19 patients.

The Department is closely monitoring the evidence on the use of ivermectin as a treatment for COVID-19. A recent collection of small studies show some positive indications. However, further high quality, larger-scale studies are still needed to confirm the efficacy of this treatment. The Therapeutics Taskforce will keep the position on ivermectin under review as more data becomes available.